Materials and Methods

Materials
Reagents used include chemicals (Sigma, St. Louis, MO), propidium iodide (Molecular Probes, Eugene, OR), lipids (Avanti Polar Lipids, Alabaster, AL), fluorescent probes 1-aminonaphtlene-3,6,8-trisulfonic acid, and N,NЈ-( p-phenylenedimethylene)bis(pridinium bromide), and fura 2 (Molecular Probes), HRP-conjugated secondary Abs (Cappell, Durham, NC), and ECL reagents (Amersham Pharmacia Biotech, Piscataway, NJ).
Cells
The Jurkat T cell leukemia (American Type Culture Collection, Manassas, VA) was cultured as described (11) . Jurkat cells transfected with Bcl-2 or cytokine response modifier (CrmA) were maintained in medium supplemented with 0.5 mg/ml G418, as described (12) . Jurkat cells overexpressing Toso were sorted by flow cytometry selecting for green-fluorescent protein expression from the viral construct used for infection (13) . FL5.12 cells were grown as described (14) .
Expression and purification of recombinant granulysin and purification of perforin
Recombinant granulysin was expressed and purified as described (1) . Briefly, recombinant 9-kDa granulysin was expressed using the vector pET28a (Novagen, Madison, WI). Fusion protein was purified in 6 M guanidine HCl on nickel affinity resin. After refolding and dialysis, the histidine tag was removed by thrombin cleavage, and the material was further purified by reverse-phase HPLC. After lyophilization, the protein was suspended in PBS, and concentration was determined using a protein assay (Bio-Rad, Hercules, CA) with lysozyme as a standard. Human perforin was purified by metal-affinity chromatography from the human NK cell line YT2C2, as described (6) .
Liposome lysis assays
Disruption of liposomes was measured as described (15) . Briefly, the fluorescent probe 1-aminonaphtlene-3,6,8-trisulfonic acid and its collisional quencher N,NЈ-( p-phenylenedimethylene)bis(pridinium bromide) were incorporated into palmitoyloleoylphosphatidylglycerol (POPG) and palmitoyloleoylphosphatidylcholine (POPC) large unilamellar vesicles. POPC and cardiolipin (CL) were mixed in a 1:1 ratio to form large unilamellar vesicles. Release of the fluorescent probe was measured on a spectrophotometer. Liposomes (25 M phospholipids) were treated with 550 nM granulysin, and the percentage of specific lysis was calculated.
Cytotoxicity assays
Jurkat cells were seeded in 96-well plates at a density of 2 ϫ 10 5 /ml (100 l/well) in medium containing 0.1% FCS. Cells were cultured for 16 h in the presence of medium, granulysin (11), or anti-Fas mAb (CH-11, 100 ng/ml; Beckman-Coulter, Fullerton, CA). Cell death was measured by propidium iodide uptake and by gating of live cells based on forward vs side scatter. Similar results with Jurkat cells were obtained using additional cytotoxicity assays, including 51 Cr release (1), MTT assay (16) , and annexin V-FITC staining (11) . Plasma membrane integrity was measured by propidium iodide uptake after 15 min of culture in the presence of granulysin.
Measurement of mitochondrial membrane potential with Rho-123
Jurkat cells were washed, resuspended at 5 ϫ 10 5 /ml in RPMI 1640 supplemented with 0.1% FCS, and incubated for 1 h at 37°C. A total of 10 5 cells were treated with recombinant granulysin for 2 h at 37°C, washed, resuspended in PBS, and placed on an inverted coverslip chamber (pretreated with polylysine). After 5 min, 200 l of 20 M Rho-123 (Molecular Probes) was added, and the excess was washed away after 2 min. Confocal images were collected using a Molecular Dynamics (Sunnyvale, CA) MultiProbe 2010 Confocal Laser Scanning Microscope, with a Nikon Diaphot 200 inverted with epi-fluorescence attachment. A krypton/argon laser with 488-nm excitation and a 590-nm long pass emission filter was used to collect images through a ϫ60 (oil) objective. After images had been collected, 200 l of 2 M carbonyl cyanide m-chlorophenylhydrazone (CCCP; Sigma) was added to the cells in the chamber, and, after 30 s, additional images were collected. Results are representative of 10 fields for each sample.
Ca 2ϩ flux measurements
Jurkat cells were loaded with fura 2 in a 1:1 vol of cell suspension with dye by incubating at 37°C for 60 min. The cells were then washed twice with buffer and incubated for a further 30 min for complete deesterification. The induction of a calcium flux was observed using an Attofluor digital fluorescence microscope (Atto Instruments, Rockville, MD). Cell suspension was loaded into chambers and, after ϳ20 s, these cells were treated with ionomycin or granulysin. The Ca 2ϩ -dependent fluorescence signal was obtained using excitation at 340 and 380 nm and ratioing the fluorescence intensities detected at 510 nm.
Subcellular fractionation and Western blot analysis
Mitochondrial and cytosolic (S100) fractions were prepared by resuspending FL5.12 cells in 0.8 ml ice-cold buffer A (250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 17 g/ml PMSF, 8 g/ml aprotinin, 2 g/ml leupeptin (pH 7.4)). Cells were homogenized using a prechilled cylinder cell homogenizer (H&Y Enterprise, Redwood City, CA). Unlysed cells and nuclei were pelleted at 750 ϫ g for 10 min, and the supernatant was centrifuged at 10,000 ϫ g for 25 min. The pellet, representing the mitochondrial fraction, was resuspended in buffer A, and the supernatant was subjected to further centrifugation at 100,000 ϫ g for 1 h. The supernatant from the final centrifugation represents the S100 fraction. Equivalent amounts of mitochondrial and S100 fractions were subjected to Western blot analysis, as previously described (14) . The primary Abs were either a 1/1000 dilution of the 7H8.2C12 cytochrome c mAb (a gift from R. Jemmerson, Department of Microbiology and Center for Immunology, University of Minnesota, Minneapolis, MN) in TBS, 0.2% Tween 20; or 10 ng/ml 20E8-C12 cytochrome oxidase subunit IV mAb (Molecular Probes) as a control for mitochondrial inner membrane integrity.
For caspases 3 and 9, Jurkat cells were treated with 50 M granulysin for 3 h and washed, and whole-cell lysates were prepared by lysing cells in 2% SDS, 137 mM NaCl, 2.7 mM KCl, and 8 mM NaHPO 4 (pH 7.4) (17, 18) . Samples were separated on 15% SDS-PAGE and electroblotted to polyvinylidene difluoride membranes. Membranes were blocked in 5% nonfat milk, 0.1% Tween 20 in TBS and then incubated with specific Abs to caspase 9 (Cell Signaling Technologies, Beverly, MA) or caspase 3 (BD PharMingen, San Diego, CA) and ␣-actin (Calbiochem, La Jolla, CA). Primary Abs were detected by peroxidase-labeled secondary Ab and developed using ECL (Amersham Pharmacia Biotech) and exposure to film.
Xenopus egg extracts and incubations
Recombinant truncated human Bid (tBid) was produced as previously described (19) . Xenopus egg mitochondria were isolated as previously described (20) . Mitochondrial incubations were reconstituted from mitochondria (1 mg/ml; biuret method) in buffer A (250 mM sucrose, 20 mM HEPES/KOH (pH 7.5), 100 mM KCl, 2.5 mM MgCl 2 , 1 mM DTT, 5 g/ml cytochalasin B, and 50 g cycloheximide) and an ATP-regenerating system of 10 mM phosphocreatine, 2 mM ATP, and 150 g/ml creatine phosphokinase. To examine mitochondrial cytochrome c content, extract aliquots (10 l) were removed at 3 h and mixed with 0.5 ml buffer A before centrifugation (12,000 ϫ g, 5 min) to pellet mitochondria. Western blot of mitochondrial cytochrome c was performed as described previously (19) .
Results
Granulysin induces membrane disruption by interaction with lipids
Granulysin, a lytic molecule of human CTL and NK cell granules, is homologous to the SAPLIP family of lipid-binding proteins (1) . The homology of granulysin to saposins suggests that it may exert its lytic activity via interaction with membrane lipids. To assess granulysin interaction with lipids, the lytic effect of granulysin on synthetic liposomes of defined composition was examined (Fig.  1A) . Negatively charged POPG liposomes were disrupted, whereas neutral POPC liposomes were not. Liposomes consisting of a mixture of POPC and CL, a negatively charged lipid, were disrupted by granulysin, indicating that lysis was associated with negatively charged lipids. Disruption of liposomes by granulysin was dependent on both granulysin (Fig. 1B ) and lipid concentration (Fig. 1C) .
In these experiments, we reproducibly detect significant disruption of liposomes at granulysin concentrations as low as 0.1 M. Thus, granulysin, like other SAPLIP family members, interacts with lipid membranes.
The ability of recombinant granulysin to disrupt membranes of nucleated mammalian cells was assessed by treating the human T cell tumor Jurkat with granulysin and monitoring uptake of propidium iodide. Within 30 min, 49.5% of granulysin-treated Jurkat cells were propidium iodide positive, as compared with 21.6% of control-treated cells, indicative of granulysin-induced membrane disruption (Fig. 2) . Perforin is shown as a positive control for membrane disruption. The combination of granulysin and perforin was additive rather than synergistic, indicating that these two molecules act independently to induce membrane damage (data not shown). Thus, granulysin perturbs the plasma membrane by a direct interaction with lipids. This activity is accompanied by nuclear condensation, membrane ruffling, and annexin V-FITC staining, as previously described (11) .
Granulysin-induced apoptosis involves mitochondrial release of cytochrome c
Bcl-2 protects cells from the mitochondrial apoptotic pathway (21), whereas CrmA protects cells from death receptor-induced apoptosis by inhibiting several caspases (22) . Jurkat cells transfected with the genes for Bcl-2 or CrmA (12) were protected to some extent against granulysin-induced death relative to vector controls (Fig. 3) . Bcl-2 protection indicates that the apoptotic pathway induced by granulysin involves mitochondrial damage (21) , whereas CrmA protection further implicates caspases in the death pathway (22) .
The ability of granulysin to induce mitochondrial damage was assessed by measuring mitochondrial transmembrane potential (⌬) (Fig. 4) . Rho-123 is a cationic fluorophore that is taken up and concentrated in electronegative mitochondria in response to the ⌬. CCCP is a protonophore that disrupts the ⌬, leading to the dissipation of the dye into the cytoplasm (23) (24) (25) . Jurkat cells incubated in medium plus Rho-123 show a punctate fluorescence (Fig. 4A ) that is abolished in cells after the addition of CCCP (Fig.  4B ). Granulysin-treated cells do not stain with Rho-123 (Fig. 4C) , and addition of CCCP does not cause any change in the staining (Fig. 4D) . Similar results were obtained with DiOC6 (3) and JC-1, two other potential sensitive dyes (not shown). Bcl-2 protection from granulysin-induced death suggests that cytochrome c release from mitochondria may initiate caspase activation, because one effect of Bcl-2 is to prevent the release of cytochrome c (26) . Therefore, we next assayed for the release of cytochrome c from the mitochondria of granulysin-treated cells. Within 1 h of granulysin treatment, cytochrome c was detectable in cytosolic extracts of granulysin-treated target cells, whereas the inner membrane protein cytochrome oxidase remained in the mitochondrial fraction (Fig. 5A) , implicating granulysin-induced cytochrome c release as an initiating signal for caspase activation.
Because granulysin disrupts the cell plasma membrane, internalized granulysin may directly damage mitochondria, effecting cytochrome c release. We tested the ability of granulysin to directly damage mitochondria in vitro. Isolated mitochondria were treated with either granulysin or tBid and analyzed for loss of cytochrome c in the mitochondrial pellet. In contrast to tBid, which caused release of cytochrome c from mitochondria, 50 M granulysin did not disrupt isolated mitochondria (Fig. 5B) , indicating that the mitochondrial disruption observed in cells is not a direct effect of pure granulysin.
One indirect mechanism by which granulysin-induced plasma membrane damage could affect mitochondria is through an influx of ions across the plasma membrane. Granulysin could induce an influx of Ca 2ϩ across the plasma membrane, which would induce permeability transition, secondary swelling of mitochondria, rupture, and release of cytochrome c. Chelating divalent cations with EDTA partially inhibits granulysin-induced death in chromium release assays of labeled target cells (Fig. 6A ), but does not affect the ability of granulysin to disrupt cell membranes (Fig. 6B) or liposomes (data not shown). The calcium flux induced by granulysin was directly detected by the use of the dye fura 2. Jurkat cells loaded with fura 2 and treated with either ionomycin or granulysin show a rapid increase in fluorescence, indicative of a calcium flux into the cytosol (Fig. 6C) . Thus, there is a requirement for extracellular ions in granulysin-induced apoptosis, and an ion flux induced by disruption of the plasma membrane may initiate cell death. Additionally, these data show that unlike perforin, there is not a requirement for calcium in granulysin-induced membrane damage, indicating a distinct mechanism for granulysin-induced plasma membrane disruption.
Caspases in granulysin-induced death
Granulysin-induced apoptosis involves caspases, as both CrmA and benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone partially protect target cells. To identify specific caspases involved in granulysin-induced death, we examined three initiator caspases involved in Fas-, granzyme B-, and genotoxic-mediated apoptosis.
The cowpox serpin CrmA inhibits death pathways mediated by Fas and chemotherapeutic agents (27) . We observed that CrmA, an inhibitor of serine and cysteine proteases, including caspase 8 (28), protects from granulysin-induced death (Fig. 3) . Because the Jurkat-Bcl-2 transfectant is resistant to granulysin but is susceptible to Fas-induced death, it is unlikely that the defined death receptor pathway is involved in granulysin-induced apoptosis. To further evaluate the role of caspase 8 in the granulysin-mediated pathway, we tested the ability of another inhibitor to protect Jurkat cells from granulysin-induced death. Nolan and coworkers (13) identified a molecule designated Toso that inhibits Fas-and Fas-associated death domain protein-induced apoptosis. Toso prevents cell death by inducing the expression of cellular Fas-associated death domain-like IL-1-converting enzyme inhibitory protein (29) and blocking adapter-induced caspase 8 activation (30) . Jurkat cells expressing Toso were protected from anti-Fas-induced death, but were not protected from granulysin-induced death (data not shown), again indicating that granulysin-induced death is different from the death receptor signaling pathway mediated by Fas.
Caspase 3 is a substrate for granzyme B (5, 6). Previously, we reported minimal processing of procaspase 3 in granulysin-treated cells and that N-acetyl-Asp-Glu-Val-Asp aldehyde, a peptide inhibitor of caspase 3-like enzymes, only weakly protected against granulysin-induced apoptosis of Jurkat cells (11) . In those experiments, cells were incubated with granulysin for 16 h before measuring apoptosis or procaspase 3 cleavage. Because granulysinmediated damage is detectable much earlier, we decided to assay procaspase 3 activation at earlier times. As shown in Fig. 7 , procaspase 3 is processed to some extent in cells treated for 3 h with 50 M granulysin or 2 M staurosporin.
Caspase 3 is an effector caspase that can be activated downstream of caspase 8 or caspase 9. Experiments using cells overexpressing Toso showed that caspase 8 is not activated. Therefore, we turned our attention to activation of caspase 9. When cytochrome c is released from mitochondria, it binds Apaf-1, which recruits procaspase 9, leading to caspase 9 activation (31) and initiation of the caspase cascade induced by genotoxic agents. Immunoblots using a caspase 9-specific antiserum were conducted on the same lysates that showed processing of procaspase 3 after a 3-h incubation with either granulysin-or staurosporine-treated cells (Fig. 7) . Processing of caspase 9 in staurosporine-treated cells is apparent. However, processed forms of caspase 9 were not detected in granulysin-treated cells. Thus, granulysin induces the activation of caspase 3 by a mechanism that is independent of processing of caspase 9.
Discussion
Granulysin, a novel effector molecule of human CTL and NK cells, is bactericidal (3) and induces apoptosis in mammalian cells (11) . CTL are capable of killing intracellular bacteria via a granulemediated mechanism (32) , and granulysin is a bactericidal molecule present in CTL granules (3). We previously suggested that granulysin interacts directly with lipids in cell membranes, and showed that granulysin induces lesions on the surface of M. tuberculosis consistent with a direct action on the mycobacterial glycolipid envelope (3). The current work provides further insights into how granulysin kills target cells.
In vitro, we find that granulysin strongly induces apoptosis of tumor target cells at a concentration of 50 M. This relatively high concentration is consistent with granulysin-inducing apoptosis in a receptor-independent manner (33). However, it is unlikely that such high concentrations of granulysin are necessary to effect target cell lysis in vivo. In vivo, granulysin would be delivered in a relatively concentrated form at the junction of the CTL/target (4). Furthermore, granulysin most likely works in concert with other constituents of cytolytic granules, as previously shown for both granzymes and perforin. Finally, conditions in the local environment will also affect granulysin-mediated lysis, because protein, salt, and H ϩ can alter the lytic activity of recombinant granulysin (34) . An immediate effect of granulysin on target cells is disruption of plasma membrane integrity. Positively charged granulysin lyses negatively charged, but not neutral, liposomes. NK-lysin, the SAP-LIP family member with the greatest homology to granulysin (35) , also affects lipid membranes (36) . NK-lysin disrupts lipid vesicles and induces random current fluctuations through a planar lipid membrane when voltage is applied across the membrane, indicating that the lipid membrane-disrupting activity of NK-lysin does not involve formation of a stable pore (36). Our findings suggest a similar mechanism of action for granulysin. Unlike the pore-forming molecule perforin (37), granulysin-induced membrane damage leads to activation of the apoptotic machinery. Granulysin disruption of the plasma membrane leads to a calcium flux that may in turn damage mitochondria. Mitochondrial damage is apparent within minutes of cell surface exposure to granulysin, but this effect is indirect in that recombinant granulysin is incapable of directly damaging isolated mitochondria in vitro. The inability of granulysin to directly disrupt the mitochondrial membrane may be either due to differences between the lipid compositions of the plasma membrane and mitochondrial membrane or that an intermediate is involved in transmitting the granulysin signal. One candidate for such an intermediate is an ion flux. We show that EDTA partially inhibits granulysin-induced death in chromium release assays, but it has no effect on the membranolytic properties of granulysin. Furthermore, there is a rapid rise in intracellular Ca 2ϩ associated with granulysin treatment of cells, suggesting that plasma membrane damage may provoke mitochondrial damage and cytochrome c release.
Previous studies with caspase inhibitors indicated that caspase activation is involved in granulysin-mediated cell death (11) . In the present study, we further evaluated the role of caspases in the granulysin pathway. A transfectant overexpressing the serpin CrmA protected against granulysin-mediated cell death. CrmA is reported to preferentially inhibit caspase 8 and caspase 1 at the concentrations generally present in transfections (28), but our experiments using Toso transfectants indicate that death receptors are not involved in granulysin-mediated cell death (13) . Toso expression induces Fas-associated death domain-like IL-1-converting enzyme inhibitory protein expression, which acts to protect cells from Fas-and Fas-associated death domain protein-induced death (29) . We find that, although Toso-expressing Jurkat are protected from anti-Fas, they are not protected from granulysin. Thus, granulysin-induced death is not dependent on the death receptor pathway mediated by Fas.
Consistent with this conclusion, Jurkat cells overexpressing Bcl-2 showed only weak protection from anti-Fas-induced death (Fig. 3) , indicating that our Jurkat cell line is not a type II cell in which the death receptor and mitochondrial death pathways intersect (38) . As these cells are protected from granulysin-induced death, the granulysin pathway is clearly distinct from the death receptor pathway mediated by Fas.
The antiapoptotic effect of Bcl-2 on granulysin-induced apoptosis suggests that mitochondrial damage is a critical step in granulysin-induced apoptosis (21) . Apaf-1, the mammalian ced-4 homologue, binds cytosolic cytochrome c and recruits procaspase 9, leading to activation. Although we are unable to detect processing of procaspase 9 in granulysin-treated cells, it has been reported that unprocessed procaspase 9, when complexed with cytochrome c and dATP, can activate downstream caspases (39) . It is also possible that low levels of processed caspase 9, sufficient to cause apoptosis but undetectable by immunoblot, may be present in granulysin-treated cells. Alternatively, activation of caspase 3 may occur by a caspase 9-independent mechanism. Disruption of ⌬ in mitochondria releases not only cytochrome c, but also a number of other molecules, including apoptosis-inducing factor (AIF). AIF is sufficient to activate endonucleases in isolated nuclei (40 -42) . Anel and coworkers have recently demonstrated that AIF is released from mitochondria in cells treated with granulysin. 5 A large number of loss of function studies performed by many laboratories over the last 5 years have clearly delineated the roles of perforin/granzymes and Fas systems for CTL-mediated cytotoxicity (43, 44) . It is clear from these papers that most of the measurable in vitro cytotoxicity delivered by CTL in the reported systems can be attributed to these two pathways. This calls into question the biologic function of granulysin in other than an accessory role. We have been unable to identify a murine homologue for granulysin using a variety of approaches. Granulysin-specific antisera fail to Western blot a protein from mouse CTL extracts; no signal is obtained using several murine CTL/NK cell cDNA or genomic libraries probed with radiolabeled granulysin cDNA; and no murine homologue is present in databases. This observation is reminiscent of other antimicrobial peptides such as human defensins for which there are no structural murine homologues (45) . Thus, granulysin appears not to have a mouse homologue that could conceivably complement the deficiency of perforin or granzyme B in knockout mice. Murine systems, including knockouts, cannot conclusively determine the functional role for granulysinor other species-specific proteins in humans. It should also be noted that the various reported systems only address limited biologic functions. For example, granulysin may be important in local environments such as the gut or CNS. Although no granulysin knockout is possible in mice because there is no homologue, experiments with human granulysin transgenic mice are planned.
CTL evolved to induce target cell death via several pathways (4). Apoptosis is initiated by the delivery of granzymes through granule exocytosis and by stimulation of cell surface death receptors (46) . Granzyme B activates several substrates, including caspase 3 (5, 6), whereas death receptor pathways of the TNF family, like Fas, use caspase 8 as the initiator (9) . In this study, using a variety of approaches, we show that granulysin disrupts cell membranes, damages mitochondria, and causes release of cytochrome c and other factors (21) . Thus, granulysin, a member of the SAPLIP family, acts via a distinct molecular mechanism for induction of target cell death by CTL and NK cells.
